Dr Klaus Menges, BfArM to Present at Pharma IQ’s Successful eCTD Lifecycle Management

London, United Kingdom, April 14, 2010 --(PR.com)-- Dr Klaus Menges knowledge and expertise in the area of eCTD submission and the surrounding regulations are well recognised by the global eCTD community, and IQPC are thrilled to announce his involvement in their April meeting in London.

Klaus will join 6 other leading regulatory bodies at the Successful eCTD Lifecycle Management conference in a key panel discussion focused on the current eCTD regulatory landscape, working towards bringing about standardisation across Europe and also answering key question posed by the delegation.

Nichola Welch, Event Director at Pharma IQ responded to the confirmation saying “This is a great opportunity for eCTD professionals to gain access to 7 leading regulatory body eCTD experts from UK, Germany, Switzerland, Sweden, Latvia, Hungary and Slovenia. It also poses a rare opportunity to gain clarification over specific challenges people are currently facing in the area and to give important feedback to the regulatory bodies.

Joining the regulatory bodies at the 2 day conference are key professionals from the EFPIA eCTD and PIM committees as well as leading eCTD experts working within Pharmaceutical companies.

For more information on Successful eCTD Lifecycle Management, please visit www.ectdevent.com

###